New Delhi: Bharat Biotech, which has a stockpile of more than 50 million doses of Covaxin ready to be distributed as required, is well-tolerated and immunogenic in the paediatric population ...
New Delhi: The World Health Organization (WHO) is likely to decide on including Bharat Biotech’s COVID-19 vaccine Covaxin in the emergency use list (EUL) within four to six weeks. WHO ...
Bhubaneswar: In another measure to speed up the COVID-19 vaccination process, Bhubaneswar Municipal Corporation (BMC) has announced walk-in facilities for all age groups for second dose of Covaxin. All those ...
Berhampur: As part of the vaccination drive against COVID-19, the Ganjam district administration will start giving Covaxin jabs to eligible recipients from Monday. Till now, Covaxin was limited to Bhubaneswar ...
Hyderabad: The final analysis of Covaxin's efficacy from phase 3 clinical trials have been released. The overall efficacy of the COVID-19 is 77.8 per cent, said Bharat Biotech. Covaxin efficacy ...
Bhubaneswar: Odisha Government on Friday decided to introduce Covaxin vaccine in Ganjam district for inoculation of people aged 18 years and above. The vaccine will be rolled out in Ganjam ...
Washington: The US’ National Institute of Health has said that India’s Bharat Biotech-developed Covaxin effectively neutralises both Alpha and Delta variants of COVID-19. According to NIH, results of a couple ...
Bhubaneswar: COVID-19 vaccines are available for free at government centres. If you want to take the vaccines at private hospitals, you have to pay for them. Here are the prices ...
New Delhi: As the threat of a third wave of COVID-19 looms, India is eagerly awaiting a vaccine for children. Especially as some experts fear that children could be more ...
New Delhi: AstraZeneca joins other vaccines that are effective against the Delta variant. COVID-19 Vaccine AstraZeneca offers high levels of protection against the Delta variant (B.1.617.2; formerly the ‘Indian ...
Copyright © 2026 Frontier Media
